Cargando…

HMGB1/Advanced Glycation End Products (RAGE) does not aggravate inflammation but promote endogenous neural stem cells differentiation in spinal cord injury

Receptor for advanced glycation end products (RAGE) signaling is involved in a series of cell functions after spinal cord injury (SCI). Our study aimed to elucidate the effects of RAGE signaling on the neuronal recovery after SCI. In vivo, rats were subjected to SCI with or without anti-RAGE antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hongyu, Mei, Xifan, Cao, Yang, Liu, Chang, Zhao, Ziming, Guo, Zhanpeng, Bi, Yunlong, Shen, Zhaoliang, Yuan, Yajiang, Guo, Yue, Song, Cangwei, Bai, Liangjie, Wang, Yansong, Yu, Deshui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583351/ https://www.ncbi.nlm.nih.gov/pubmed/28871209 http://dx.doi.org/10.1038/s41598-017-10611-8

Ejemplares similares

Netrin-1 Improves Functional Recovery through Autophagy Regulation by Activating the AMPK/mTOR Signaling Pathway in Rats with Spinal Cord Injury
por: Bai, Liangjie, et al.
Publicado: (2017)

Berberine attenuated pro-inflammatory factors and protect against neuronal damage via triggering oligodendrocyte autophagy in spinal cord injury
por: Wang, Hongyu, et al.
Publicado: (2017)

The Role of Netrin-1 in Improving Functional Recovery through Autophagy Stimulation Following Spinal Cord Injury in Rats
por: Bai, Liangjie, et al.
Publicado: (2017)

Protein hairy enhancer of split-1 expression during differentiation of muscle-derived stem cells into neuron-like cells★
por: Huang, Mina, et al.
Publicado: (2012)

The Neuroprotective Effects of Muscle-Derived Stem Cells via Brain-Derived Neurotrophic Factor in Spinal Cord Injury Model
por: Han, Donghe, et al.
Publicado: (2017)

Green tea polyphenols protect spinal cord neurons against hydrogen peroxide-induced oxidative stress
por: Zhao, Jianbo, et al.
Publicado: (2014)

Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β‐catenin signaling pathway after spinal cord injury
por: Gao, Kai, et al.
Publicado: (2016)

Neuroprotective Effect of Simvastatin via Inducing the Autophagy on Spinal Cord Injury in the Rat Model
por: Gao, Kai, et al.
Publicado: (2015)

Expression and Significance of High-Mobility Group Protein B1 (HMGB1) and the Receptor for Advanced Glycation End-Product (RAGE) in Knee Osteoarthritis
por: Sun, Xue-Hui, et al.
Publicado: (2016)

Nischarin attenuates apoptosis induced by oxidative stress in PC12 cells
por: Guo, Zhanpeng, et al.
Publicado: (2019)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

Activation of the Nrf2/ARE signaling pathway by probucol contributes to inhibiting inflammation and neuronal apoptosis after spinal cord injury
por: Zhou, Zipeng, et al.
Publicado: (2017)

The Immune Tolerance Role of the HMGB1-RAGE Axis
por: Watanabe, Haruki, et al.
Publicado: (2021)

Gold nanoclusters conjugated berberine reduce inflammation and alleviate neuronal apoptosis by mediating M2 polarization for spinal cord injury repair
por: Zhou, Zipeng, et al.
Publicado: (2021)

sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells
por: Zhang, Fang, et al.
Publicado: (2017)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

The role of receptor for advanced glycation endproducts (RAGE) in infection
por: van Zoelen , Marieke AD, et al.
Publicado: (2011)

The Role of Receptor for Advanced Glycation Endproducts (RAGE) in Infection
por: van Zoelen, M. A. D., et al.
Publicado: (2011)

Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway
por: Yuan, Yajiang, et al.
Publicado: (2022)

Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
por: Li, Lingzhao, et al.
Publicado: (2022)

Remote Ischemic Postconditioning Protects against Myocardial Ischemia-Reperfusion Injury by Inhibition of the RAGE-HMGB1 Pathway
por: Wang, Xiangming, et al.
Publicado: (2018)

Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
por: Pilzweger, Christin, et al.
Publicado: (2015)

Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis
por: Szczepanski, Miroslaw J., et al.
Publicado: (2014)

Mechanism of HMGB1–RAGE in Kawasaki disease with coronary artery injury
por: Qian, Biying, et al.
Publicado: (2020)

RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2021)

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
por: Singh, Harbinder, et al.
Publicado: (2022)

HMGB1/RAGE axis mediates the apoptosis, invasion, autophagy, and angiogenesis of the renal cell carcinoma
por: Wu, Cun-Zao, et al.
Publicado: (2018)

Soluble Forms of the Receptor for Advanced Glycation Endproducts (RAGE) in Periodontitis
por: Detzen, Laurent, et al.
Publicado: (2019)

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling
por: Reed, James C., et al.
Publicado: (2020)

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
por: Drake, Lindsey R., et al.
Publicado: (2020)

Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
por: Song, Juhyun, et al.
Publicado: (2014)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
por: Yang, Huan, et al.
Publicado: (2019)

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
por: Humpert, Per M, et al.
Publicado: (2007)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors
por: Khambu, Bilon, et al.
Publicado: (2020)

Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
por: Lai, Weixin, et al.
Publicado: (2021)

RAGE, Receptor of Advanced Glycation Endoproducts, Negatively Regulates Chondrocytes Differentiation
por: Kosaka, Tatsuya, et al.
Publicado: (2014)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjuacjse4ukm9vpuovqfn9t1cl